422 related articles for article (PubMed ID: 25755608)
1. The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.
Kumar A; Acharya SK; Singh SP; Saraswat VA; Arora A; Duseja A; Goenka MK; Jain D; Kar P; Kumar M; Kumaran V; Mohandas KM; Panda D; Paul SB; Ramachandran J; Ramesh H; Rao PN; Shah SR; Sharma H; Thandassery RB;
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S3-S26. PubMed ID: 25755608
[TBL] [Abstract][Full Text] [Related]
2. 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.
Kumar A; Acharya SK; Singh SP; Arora A; Dhiman RK; Aggarwal R; Anand AC; Bhangui P; Chawla YK; Datta Gupta S; Dixit VK; Duseja A; Kalra N; Kar P; Kulkarni SS; Kumar R; Kumar M; Madhavan R; Mohan Prasad VG; Mukund A; Nagral A; Panda D; Paul SB; Rao PN; Rela M; Sahu MK; Saraswat VA; Shah SR; Shalimar ; Sharma P; Taneja S; Wadhawan M;
J Clin Exp Hepatol; 2020; 10(1):43-80. PubMed ID: 32025166
[TBL] [Abstract][Full Text] [Related]
3. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.
Arora A; Singh SP; Kumar A; Saraswat VA; Aggarwal R; Bangar M; Bhaumik P; Devarbhavi H; Dhiman RK; Dixit VK; Goel A; Goswami B; Kapoor D; Madan K; Narayan J; Nijhawan S; Pandey G; Rai RR; Sahu MK; Saraf N; Shalimar ; Shenoy T; Thomas V; Wadhawan M;
J Clin Exp Hepatol; 2018 Mar; 8(1):58-80. PubMed ID: 29743798
[TBL] [Abstract][Full Text] [Related]
4. Current practices in management of hepatocellular carcinoma in India: results of an online survey.
Kumar A
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S140-6. PubMed ID: 25755606
[TBL] [Abstract][Full Text] [Related]
5. 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations.
Kumar A; Acharya SK; Singh SP; Duseja A; Madan K; Shukla A; Arora A; Anand AC; Bahl A; Soin AS; Sirohi B; Dutta D; Jothimani D; Panda D; Saini G; Varghese J; Kumar K; Premkumar M; Panigrahi MK; Wadhawan M; Sahu MK; Rela M; Kalra N; Rao PN; Puri P; Bhangui P; Kar P; Shah SR; Baijal SS; Shalimar ; Paul SB; Gamanagatti S; Gupta S; Taneja S; Saraswat VA; Chawla YK
J Clin Exp Hepatol; 2024; 14(1):101269. PubMed ID: 38107186
[TBL] [Abstract][Full Text] [Related]
6. Resection for hepatocellular carcinoma.
Ramesh H
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S90-6. PubMed ID: 25755617
[TBL] [Abstract][Full Text] [Related]
7. Treatment algorithms for managing hepatocellular carcinoma.
Saraswat VA; Pandey G; Shetty S
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S80-9. PubMed ID: 25755616
[TBL] [Abstract][Full Text] [Related]
8. Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy.
Arora A; Kumar A; Anand AC; Puri P; Dhiman RK; Acharya SK; Aggarwal K; Aggarwal N; Aggarwal R; Chawla YK; Dixit VK; Duseja A; Eapen CE; Goswami B; Gujral K; Gupta A; Jindal A; Kar P; Kumari K; Madan K; Malhotra J; Malhotra N; Pandey G; Pandey U; Puri RD; Rai RR; Rao PN; Sarin SK; Sharma A; Sharma P; Shenoy KT; Singh KR; Singh SP; Suri V; Trehanpati N; Wadhawan M
J Clin Exp Hepatol; 2019; 9(3):383-406. PubMed ID: 31360030
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
Pahari H; Raj A; Sawant A; Ahire DS; Rathod R; Rathi C; Sankalecha T; Palnitkar S; Raut V
World J Transplant; 2024 Mar; 14(1):88833. PubMed ID: 38576752
[TBL] [Abstract][Full Text] [Related]
10. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
[TBL] [Abstract][Full Text] [Related]
11. Clinical Profile, Patterns of Care & adherence to Guidelines in Patients with Hepatocellular Carcinoma: Prospective multi-center Study.
Shukla A; Patkar S; Sundaram S; Shah SR; Ingle M; Gupta A; Gopan A; Kamat M; Mohanka R; Singh S; Walke S; Pandey V; Goel M
J Clin Exp Hepatol; 2022; 12(6):1463-1473. PubMed ID: 36340319
[TBL] [Abstract][Full Text] [Related]
12. Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).
Duseja A; Singh SP; De A; Madan K; Rao PN; Shukla A; Choudhuri G; Saigal S; Shalimar ; Arora A; Anand AC; Das A; Kumar A; Eapen CE; Devadas K; Shenoy KT; Panigrahi M; Wadhawan M; Rathi M; Kumar M; Choudhary NS; Saraf N; Nath P; Kar S; Alam S; Shah S; Nijhawan S; Acharya SK; Aggarwal V; Saraswat VA; Chawla YK
J Clin Exp Hepatol; 2023; 13(2):273-302. PubMed ID: 36950481
[TBL] [Abstract][Full Text] [Related]
13. Role of liver transplantation for hepatocellular carcinoma.
Kumaran V
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S97-S103. PubMed ID: 25755618
[TBL] [Abstract][Full Text] [Related]
14. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes.
Mukund A; Vats P; Jindal A; Patidar Y; Sarin SK
J Clin Exp Hepatol; 2020; 10(6):563-573. PubMed ID: 33311893
[TBL] [Abstract][Full Text] [Related]
15. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.
Arora A; Kumar A; Prasad N; Duseja A; Acharya SK; Agarwal SK; Aggarwal R; Anand AC; Bhalla AK; Choudhary NS; Chawla YK; Dhiman RK; Dixit VK; Gopalakrishnan N; Gupta A; Hegde UN; Jasuja S; Jha V; Kher V; Kumar A; Madan K; Maiwall R; Mathur RP; Nayak SL; Pandey G; Pandey R; Puri P; Rai RR; Raju SB; Rana DS; Rao PN; Rathi M; Saraswat VA; Saxena S; Shalimar ; Sharma P; Singh SP; Singal AK; Soin AS; Taneja S; Varughese S
J Clin Exp Hepatol; 2021; 11(3):354-386. PubMed ID: 33994718
[TBL] [Abstract][Full Text] [Related]
16. Liver Transplantation in India: At the Crossroads.
Nagral S; Nanavati A; Nagral A
J Clin Exp Hepatol; 2015 Dec; 5(4):329-40. PubMed ID: 26900275
[TBL] [Abstract][Full Text] [Related]
17. Correlation of baseline Portal pressure (hepatic venous pressure gradient) and Indocyanine Green Clearance Test With Post-transarterial Chemoembolization Acute Hepatic Failure.
Khisti R; Patidar Y; Garg L; Mukund A; Thomas SS; Sarin SK
J Clin Exp Hepatol; 2019; 9(4):447-452. PubMed ID: 31516260
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
Jearth V; Patil PS; Mehta S; Sundaram S; Seth V; Goel M; Patkar S; Bal M; Rao V
J Clin Exp Hepatol; 2022; 12(3):841-852. PubMed ID: 35677513
[TBL] [Abstract][Full Text] [Related]
19. Current management of hepatocellular carcinoma.
Crissien AM; Frenette C
Gastroenterol Hepatol (N Y); 2014 Mar; 10(3):153-61. PubMed ID: 24829542
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic approach to hepatocellular carcinoma].
Schacherer D; Schoelmerich J; Zuber-Jerger I
Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
